Osteogenic-angiogenic coupled response of cobalt-containing mesoporous bioactive glasses in vivo
Source abstract
Abstract
The incorporation of cobalt ions into the composition of bioactive glasses has emerged as a strategy of interest for bone regeneration purposes. In the present work, we have designed a set of bioactive mesoporous glasses SiO2-CaO-P2O5-CoO (Co-MBGs) with different amounts of cobalt. The physicochemical changes introduced by the Co2+ ion, the in vitro effects of Co-MBGs on preosteoblasts and endothelial cells and their in vivo behaviour using them as bone grafts in a sheep model were studied. The results show that Co2+ ions neither destroy mesoporous ordering nor inhibit in vitro bioactive behaviour, exerting a dual role as network former and modifier for CoO concentrations above 3% mol. On the other hand, the activity of Co-MBGs on MC3T3-E1 preosteoblasts and HUVEC vascular endothelial cells is dependent on the concentration of CoO present in the glass. For low Co-MBGs concentrations (1mg/ml) cell viability is not affected, while the expression of osteogenic (ALP, RUNX2 and OC) and angiogenic (VEGF) genes is stimulated. For Co-MBGs concentration of 5 mg/ml, cell viability decreases as a function of the CoO content. In vivo studies show that the incorporation of Co2+ ions to the MBGs improves the bone regeneration activity of these materials, despite the deleterious effect that this ion has on bone-forming cells for any of the Co-MBG compositions studied. This contradictory effect is explained by the marked increase in angiogenesis that takes place inside the bone defect, leading to an angiogenesis-osteogenesis coupling that compensates for the partial decrease in osteoblast cells. The development of new bone grafts implies to address the need for osteogenesis-angiogenesis coupling that allows bone regeneration with viable tissue in the long term. In this sense the incorporation of cobalt ions into the composition of bioactive glasses has emerged as a strategy of great interest in this field. Due to the potential cytotoxic effect of cobalt ions, there is an important controversy regarding the suitability of their incorporation in bone grafts. In this work, we address this controversy after the implantation of cobalt-doped mesoporous bioactive glasses in a sheep model. The incorporation of cobalt ions in bioactive glasses improves the bone regeneration ability of these bone grafts, due to enhancement of the angiogenesis-osteogenesis coupling.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Spine and Intervertebral Disc Pathology · Dental Implant Techniques and Outcomes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (65)
Show source-provided references
1. Highly ordered mesoporous bioactive glasses with superior in vitro bone-forming bioactivities10.1002/anie.200460598 ↗
2. Achievements in mesoporous bioactive glasses for biomedical applications10.3390/pharmaceutics14122636 ↗
3. Mesoporous bioactive glasses for bone healing and biomolecules delivery10.1016/j.msec.2019.110180 ↗
4. Bioactive glasses entering the mainstream10.1016/j.drudis.2018.05.027 ↗
5. High-performance mesoporous bioceramics mimicking bone mineralization10.1021/cm800172x ↗
6. Mesoporous bioactive glasses: mechanical reinforcement by means of a biomimetic process10.1016/j.actbio.2011.02.012 ↗
7. Bioactive glass-based materials with hierarchical porosity for medical applications: review of recent advances10.1016/j.actbio.2016.06.033 ↗
8. Mesoporous bioactive glasses: structure characteristics, drug/growth factor delivery and bone regeneration application10.1098/rsfs.2011.0121 ↗
9. Development of antibiotic loaded mesoporous bioactive glass and its drug release kinetics10.1016/j.ceramint.2019.10.264 ↗
10. Injectability, processability, drug loading, and antibacterial activity of gentamicin-impregnated mesoporous bioactive glass composite calcium phosphate bone cement in vitro10.3390/biomimetics7030121 ↗
11. Osteostatin potentiates the bioactivity of mesoporous glass scaffolds containing Zn2+ ions in human mesenchymal stem cells10.1016/j.actbio.2019.03.033 ↗
12. Proliferation, differentiation and gene expression of osteoblasts in boron-containing associated with dexamethasone deliver from mesoporous bioactive glass scaffolds10.1016/j.biomaterials.2011.06.009 ↗
13. Research on the biological activity and doxorubicin release behavior in vitro of mesoporous bioactive SiO2 -CaO-P2O5 glass nanospheres10.1016/j.apsusc.2017.05.078 ↗
14. Mesoporous bioactive glass-polyurethane nanocomposites as reservoirs for sustained drug delivery10.1016/j.colsurfb.2018.10.030 ↗
15. Multi-functional silica-based mesoporous materials for simultaneous delivery of biologically active ions and therapeutic biomolecules10.1016/j.actbio.2021.05.007 ↗
16. Nanotherapeutics for regeneration of degenerated tissue infected by bacteria through the multiple delivery of bioactive ions and growth factor with antibacterial/angiogenic and osteogenic/odontogenic capacity
17. Ag modified mesoporous bioactive glass nanoparticles for enhanced antibacterial activity in 3D infected skin model10.1016/j.msec.2019.109764 ↗
18. Multifunctional antibiotic- and zinc-containing mesoporous bioactive glass scaffolds to fight bone infection10.1016/j.actbio.2020.07.044 ↗
19. Cu-doped hollow bioactive glass nanoparticles for bone infection treatment10.3390/pharmaceutics14040845 ↗
20. Design and evaluation a kind of functional biomaterial for bone tissue engineering: selenium/mesoporous bioactive glass nanospheres10.1016/j.jcis.2020.06.122 ↗
21. Construction of tellurium-doped mesoporous bioactive glass nanparticles for bone cancer therapy by promoting ROS-mediated apoptosis and antibacterial activity10.1016/j.jcis.2021.11.122 ↗
22. The incorporation of strontium to improve bone-regeneration ability of mesoporous bioactive glasses10.3390/ma11050678 ↗
23. The response of pre-osteoblasts and osteoclasts to gallium containing mesoporous bioactive glasses10.1016/j.actbio.2018.06.036 ↗
24. Bioactive glasses: sprouting angiogenesis in tissue engineering10.1016/j.tibtech.2017.12.003 ↗
25. Stimulation of peri-implant vascularization with bone marrow-derived progenitor cells: monitoring by in vivo EPR oximetry10.1089/ten.2006.0225 ↗
26. Life with oxygen10.1126/science.1147949 ↗
27. Cobalt-doped bioactive glasses for biomedical applications: a review10.3390/ma16144994 ↗
28. Role of hypoxia-inducible factor-1α in angiogenic–osteogenic coupling10.1007/s00109-009-0477-9 ↗
29. Regulation of osteogenesis-angiogenesis coupling by HIFs and VEGF10.1359/jbmr.090602 ↗
30. The hypoxia-inducible factor α pathway couples angiogenesis to osteogenesis during skeletal development10.1172/JCI31581 ↗
31. Targeting HIF-1 for cancer therapy10.1038/nrc1187 ↗
32. Hypoxia promotes proliferation and osteogenic differentiation potentials of human mesenchymal stem cells10.1002/jor.21517 ↗
33. Effects of hypoxia on proliferation and osteogenic differentiation of periodontal ligament stem cells: an in vitro and in vivo study10.4238/2014.December.4.15 ↗
34. In vivo hypobaric hypoxia performed during the remodeling process accelerates bone healing in mice10.5966/sctm.2013-0209 ↗
35. Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration10.1073/pnas.0708474105 ↗
36. Cellular hypoxia promotes osteogenic differentiation of mesenchymal stem cells and bone defect healing via STAT3 signaling10.1186/s11658-019-0191-8 ↗
37. Cobalt induces hypoxia-inducible factor-1α expression in airway smooth muscle cells by a reactive oxygen species– and PI3K-dependent mechanism10.1165/rcmb.2003-0426OC ↗
38. Paradoxical effects of hypoxia-mimicking divalent cobalt ions in human endothelial cells in vitro10.1007/s11010-005-4504-z ↗
39. Stabilization of hypoxia-inducible factor-1α is involved in the hypoxic stimuli-induced expression of vascular endothelial growth factor in osteoblastic cells10.1006/cyto.2001.0985 ↗
40. Hypoxia-mimicking bioactive glass/collagen glycosaminoglycan composite scaffolds to enhance angiogenesis and bone repair10.1016/j.biomaterials.2015.02.006 ↗
41. Multi-targeted B and Co co-doped 45S5 bioactive glasses with angiogenic potential for bone regeneration10.1016/j.msec.2020.110909 ↗
42. Cobalt-containing bioactive glasses reduce human mesenchymal stem cell chondrogenic differentiation despite HIF-1α stabilisation10.1016/j.jeurceramsoc.2017.08.001 ↗
43. Strontium- and cobalt-doped multicomponent mesoporous bioactive glasses (MBGs) for potential use in bone tissue engineering applications10.3390/ma13061348 ↗
44. A simple way of modulating in vitro angiogenic response using Cu and Co-doped bioactive glasses10.1016/j.matlet.2017.12.075 ↗
45. Modulating the cobalt dose range to manipulate multisystem cooperation in bone environment: a strategy to resolve the controversies about cobalt use for orthopedic applications10.7150/thno.37931 ↗
46. Influence of cobalt ions on collagen gel formation and their interaction with osteoblasts10.1021/acsomega.8b01048 ↗
47. Hypoxia-mimicking cobalt-doped borosilicate bioactive glass scaffolds with enhanced angiogenic and osteogenic capacity for bone regeneration10.7150/ijbs.32358 ↗
48. Strontium- and cobalt-substituted bioactive glasses seeded with human umbilical cord perivascular cells to promote bone regeneration via enhanced osteogenic and angiogenic activities10.1016/j.actbio.2017.06.021 ↗
49. Evaluation of in vitro and in vivo biocompatibility and structure of cobaltreleasing sol-gel bioactive glass10.1016/j.ceramint.2018.08.022 ↗
50. Cobalt-containing bioactive glass mimics vascular endothelial growth factor A and hypoxia inducible factor 1 function10.1002/jbm.a.37095 ↗
51. In vitro and in vivo response of zinc-containing mesoporous bioactive glasses in a sheep animal model10.3390/ijms232213918 ↗
52. Solutions able to reproduce in vivo surface-structure changes in bioactive glass-ceramic A-W10.1002/jbm.820240607 ↗
53. Effects of a mesoporous bioactive glass on osteoblasts, osteoclasts and macrophages10.1016/j.jcis.2018.05.099 ↗
54. Multifunctional bioacitve glasses and glass-ceramics: beyond ‘traditional’ bioactivity
55. Cobalt promotes angiogenesis via hypoxia-inducible factor and protects tubulointerstitium in the remnant kidney model10.1038/labinvest.3700328 ↗
56. Acute intravesical infusion of a cobalt solution stimulates a hypoxia response, growth and angiogenesis in the rat bladder10.1097/01.ju.0000058406.16931.93 ↗
57. Enhancing in vivo vascularized bone formation by cobalt chloride-treated bone marrow stromal cells in a tissue engineered periosteum model10.1016/j.biomaterials.2010.01.083 ↗
58. Novel ion-doped mesoporous glasses for bone tissue engineering: study of their structural characteristics influenced by the presence of phosphorous oxide10.1016/j.jnoncrysol.2016.10.031 ↗
59. Synthesis and characterization of hypoxia-mimicking bioactive glasses for skeletal regeneration10.1039/c0jm01111h ↗
60. Cobalt-releasing 1393 bioactive glass-derived scaffolds for bone tissue engineering applications10.1021/am405354y ↗
61. Impact of transition metal ions on the structure and bioactivity of alkali-free bioactive glasses10.1016/j.jnoncrysol.2018.12.003 ↗
62. The influence of cobalt incorporation and cobalt precursor selection on the structure and bioactivity of sol–gel-derived bioactive glass10.1007/s10971-018-4823-7 ↗
63. Synthesis, physico-chemical and biological characterization of strontium and cobalt substituted bioactive glasses for bone tissue engineering10.1016/j.jnoncrysol.2016.07.025 ↗
64. Influence of foreign metal ions on crystal growth and morphology of brushite (CaHPO4, 2H2O) and its transformation to octacalcium phosphate and apatite10.1016/j.jcrysgro.2008.01.047 ↗
65. Influence of cobalt ions on collagen gel formation and their interaction with osteoblasts10.1021/acsomega.8b01048 ↗